Morgan Stanley’s Cerence CRNC Stock Holding History
Bought
Maintained
Sold
Other funds holding CRNC
ACM
PCMI
VCM
NSGL
VPM
OFCM
Morgan Stanley's CRNC Position: Q1 2026 in Review
Morgan Stanley reduced its Cerence (CRNC) stake by 44% in Q1 2026, selling an estimated $2.89M and leaving 403,381 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4591.
Morgan Stanley first reported a position in CRNC in Q4 2019 and has held it in 26 quarters since. The position peaked at $35.8M in Q2 2021. 195 funds tracked by Wall St. Rank hold CRNC as of Q1 2026.
- Morgan Stanley held 403,381 shares of Cerence worth $2.55M as of Q1 2026.
- Morgan Stanley sold 321,197 Cerence shares in Q1 2026, an estimated $2.89M.
- Cerence made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #4591 holding.
- Morgan Stanley first reported a position in Cerence in Q4 2019 and has held it in 26 quarters since.
- Morgan Stanley's Cerence position peaked at $35.8M in Q2 2021.
- 195 funds tracked by Wall St. Rank held Cerence as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.